CY1118253T1 - Υλικο βαθμονομησης για ανοσοποσοτικους προσδιορισμους - Google Patents
Υλικο βαθμονομησης για ανοσοποσοτικους προσδιορισμουςInfo
- Publication number
- CY1118253T1 CY1118253T1 CY20161101189T CY161101189T CY1118253T1 CY 1118253 T1 CY1118253 T1 CY 1118253T1 CY 20161101189 T CY20161101189 T CY 20161101189T CY 161101189 T CY161101189 T CY 161101189T CY 1118253 T1 CY1118253 T1 CY 1118253T1
- Authority
- CY
- Cyprus
- Prior art keywords
- calibration material
- immune determination
- immune
- determination
- calibration
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2496/00—Reference solutions for assays of biological material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2496/00—Reference solutions for assays of biological material
- G01N2496/05—Reference solutions for assays of biological material containing blood cells or plasma
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Analysing Materials By The Use Of Radiation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
Abstract
Χρήση ενός υλικού βαθμονόμησης, το οποίο περιλαμβάνει σωματικό υγρό θηλαστικών, για τη βαθμονόμηση ενός ανοσοπροσδιορισμού για την ανίχνευση των αυτοαντισωμάτων.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0725239.8A GB0725239D0 (en) | 2007-12-24 | 2007-12-24 | Calibrator for autoantibody assay |
US1668907P | 2007-12-26 | 2007-12-26 | |
PCT/GB2008/004260 WO2009081165A1 (en) | 2007-12-24 | 2008-12-23 | Calibrator for immunoassays |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1118253T1 true CY1118253T1 (el) | 2017-06-28 |
Family
ID=39092384
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20161101189T CY1118253T1 (el) | 2007-12-24 | 2016-11-17 | Υλικο βαθμονομησης για ανοσοποσοτικους προσδιορισμους |
Country Status (18)
Country | Link |
---|---|
US (3) | US20090176319A1 (el) |
EP (1) | EP2223114B1 (el) |
JP (1) | JP5594776B2 (el) |
CN (1) | CN101952723B (el) |
AU (1) | AU2008339624B2 (el) |
BR (1) | BRPI0821397B1 (el) |
CA (1) | CA2707025C (el) |
CY (1) | CY1118253T1 (el) |
DK (1) | DK2223114T3 (el) |
ES (1) | ES2588731T3 (el) |
GB (1) | GB0725239D0 (el) |
HK (1) | HK1152380A1 (el) |
HR (1) | HRP20161109T1 (el) |
IL (1) | IL205733A (el) |
PT (1) | PT2223114T (el) |
SG (1) | SG186684A1 (el) |
SI (1) | SI2223114T1 (el) |
WO (1) | WO2009081165A1 (el) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9810040D0 (en) | 1998-05-11 | 1998-07-08 | Univ Nottingham | Blood borne tumour markers |
GB9827228D0 (en) * | 1998-12-10 | 1999-02-03 | Univ Nottingham | Cancer detection method and reagents |
US20030232399A1 (en) * | 2000-06-14 | 2003-12-18 | Robertson John Forsyth Russell | Cancer detection methods and reagents |
GB2424273B (en) * | 2002-11-14 | 2007-06-27 | Univ Nottingham | Method for preparing tumour marker protein |
US7858323B2 (en) | 2004-06-09 | 2010-12-28 | The Regents Of The University Of Michigan | Phage microarray profiling of the humoral response to disease |
GB2426581A (en) * | 2005-05-27 | 2006-11-29 | Univ Nottingham | Immunoassay methods |
RU2636532C2 (ru) | 2005-05-27 | 2017-11-23 | Онкиммьюн Лимитед | Улучшенные способы иммуноанализа |
WO2007136026A1 (ja) * | 2006-05-19 | 2007-11-29 | Bml, Inc. | 抗原タンパク質の定量方法及び定量用キット |
US8574848B2 (en) * | 2006-09-13 | 2013-11-05 | Oncimmune Ltd. | Immunoassay methods |
WO2011116209A2 (en) | 2010-03-17 | 2011-09-22 | The Regents Of The University Of Michigan | Using phage epitopes to profile the immune response |
US11662564B2 (en) | 2017-06-15 | 2023-05-30 | Shenzhen Prs Limited | Paraffin shield coating for microscope slide |
KR102342988B1 (ko) * | 2017-06-15 | 2021-12-27 | 션전 피알에스 리미티드 | Ihc 항원 영상 척도 외삽 방법 |
BR102021003012A2 (pt) | 2020-02-19 | 2021-11-30 | Univ Berlin Charite | Métodos para o diagnóstico de infecção por sars-cov-2, kit e usos |
Family Cites Families (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4241044A (en) * | 1978-12-28 | 1980-12-23 | Abbott Laboratories | Method of diagnosing cancer by detecting elevated anti-T antibody activity |
JPS60192263A (ja) * | 1984-03-13 | 1985-09-30 | Teijin Ltd | 免疫複合体測定用標準物質及びそれを用いた免疫複合体の測定法 |
NZ211453A (en) * | 1984-03-22 | 1989-01-06 | Biotechnology Research Enterpr | Aryl azides, their preparation and use in the detection, localisation and isolation of polynucleotides |
US4937185A (en) * | 1987-07-31 | 1990-06-26 | The Ohio State University Research Foundation | Detection of circulating antibodies to a cancer marker protein |
US7282345B1 (en) * | 1989-08-04 | 2007-10-16 | Schering Ag | C-erbB-2 external domain: GP75 |
US5110911A (en) * | 1989-11-02 | 1992-05-05 | Biomira, Inc. | Human tumor-associated thomsen-friedenreich antigen |
US5157020A (en) * | 1990-05-24 | 1992-10-20 | Research Corporation Tech., Inc. | Synthetic senescent cell antigen |
DE4120412C1 (el) * | 1991-06-20 | 1993-01-07 | Henning Berlin Gmbh Chemie- Und Pharmawerk, 1000 Berlin, De | |
JPH067191A (ja) * | 1991-09-26 | 1994-01-18 | Konica Corp | モノクローナル抗体、それを産生するハイブリド−マ、その対応抗原及びそれを用いた測定方法 |
US6280962B1 (en) * | 1991-11-25 | 2001-08-28 | Yoreh Biotechnologies Ltd. | Whole blood/mitogen assay for the early detection of a subject with cancer and kit |
US6322989B1 (en) * | 1991-11-25 | 2001-11-27 | Yoreh Biotechnologies, Ltd. | Whole blood/mitogen assay for the early detection of a subject with ovarian or breast cancer and kit |
ATE275198T1 (de) * | 1991-12-02 | 2004-09-15 | Medical Res Council | Herstellung von antikörpern auf phagenoberflächen ausgehend von antikörpersegmentbibliotheken. |
WO1993015759A1 (en) * | 1992-02-12 | 1993-08-19 | Robert Perper | Autoantibody assay and usage in the control of human disease |
JPH07505719A (ja) * | 1992-04-14 | 1995-06-22 | デューク・ユニバーシティー | p53及びHSP70のコンプレックスを含む腫瘍の検出方法 |
US5801005A (en) * | 1993-03-17 | 1998-09-01 | University Of Washington | Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated |
US5763164A (en) * | 1993-04-16 | 1998-06-09 | Northwestern University | Immunogenic cancer proteins and peptides and methods of use |
US5747268A (en) * | 1993-04-22 | 1998-05-05 | Dade International Inc. | Tumor marker control |
US5744144A (en) * | 1993-07-30 | 1998-04-28 | University Of Pittsburgh University Patent Committee Policy And Procedures | Synthetic multiple tandem repeat mucin and mucin-like peptides, and uses thereof |
US5721105A (en) * | 1994-02-20 | 1998-02-24 | B.R.A.H.M.S. Diagnostica Gmbh | Method for the immunological determination of proteins and kit for carrying out the method |
US5789655A (en) * | 1994-05-13 | 1998-08-04 | The Regents Of The University Of California | Transgenic animals expressing artificial epitope-tagged proteins |
US5561049A (en) * | 1994-09-21 | 1996-10-01 | Behringwerke Ag | Method for detecting antibodies |
US5876728A (en) * | 1995-02-15 | 1999-03-02 | Howard David Kass | Natural composition extracted from plants used in the treatment of cancer |
US5723343A (en) * | 1995-08-28 | 1998-03-03 | University Of Florida | Autoantibodies in patients with acquired hypoparathyroidism and assay method therefor |
JP3472048B2 (ja) * | 1995-10-09 | 2003-12-02 | 鐘淵化学工業株式会社 | 自己免疫疾患の診断薬 |
AU3889997A (en) * | 1996-08-16 | 1998-03-06 | Johns Hopkins University School Of Medicine, The | Melanoma cell lines expressing shared immunodominant melanoma antigens nd methods of using same |
US6306636B1 (en) * | 1997-09-19 | 2001-10-23 | Arch Development Corporation | Nucleic acid segments encoding wheat acetyl-CoA carboxylase |
DE19805815C1 (de) * | 1998-02-13 | 1999-11-11 | Ansgar W Lohse | Diagnostikum zum Erkennen der autoimmunen Hepatitis |
US6388062B1 (en) * | 1998-05-08 | 2002-05-14 | The Wistar Institute Of Anatomy And Biology | Modified p53 tetramerization domains having hydrophobic amino acid substitutions |
GB9810040D0 (en) * | 1998-05-11 | 1998-07-08 | Univ Nottingham | Blood borne tumour markers |
JP3268494B2 (ja) * | 1998-10-01 | 2002-03-25 | 俊成 広畑 | 全身性エリテマトーデス病態診断剤 |
US6387639B1 (en) * | 1998-11-10 | 2002-05-14 | Sloan-Kettering Institute For Cancer Research | Ma family polypeptides and anti-Ma antibodies |
GB9827228D0 (en) * | 1998-12-10 | 1999-02-03 | Univ Nottingham | Cancer detection method and reagents |
US7807810B2 (en) * | 1999-04-08 | 2010-10-05 | The Ohio State University Research Foundation | Nucleic acids encoding the major outer membrane protein of the causative agent of human granulocytic ehrlichiosis and peptides encoded thereby |
US6645465B2 (en) * | 1999-08-06 | 2003-11-11 | Michigan, University Of The Regents | Annexin proteins and autoantibodies as serum markers for cancer |
DE19939575C1 (de) * | 1999-08-20 | 2001-08-02 | Orgentec Diagnostika Gmbh | Verfahren zur Diagnose von Sjögren-Syndrom |
US20020064801A1 (en) * | 1999-12-01 | 2002-05-30 | Ryan Jeffrey R. | Novel and practical serological assay for the clinical diagnosis of leishmaniasis |
US6667160B2 (en) * | 2000-03-15 | 2003-12-23 | Kenneth D. Fine | Method for diagnosing immunologic food sensitivity |
CA2405448A1 (en) * | 2000-03-30 | 2001-10-11 | Nippon Kayaku Kabushiki Kaisha | Method of examining cancer by assaying autoantibody against mdm2 and reagent therefor |
US20030232399A1 (en) * | 2000-06-14 | 2003-12-18 | Robertson John Forsyth Russell | Cancer detection methods and reagents |
US20030138860A1 (en) * | 2000-06-14 | 2003-07-24 | Robertson John Forsyth Russell | Cancer detection methods and reagents |
US7745141B2 (en) * | 2001-06-21 | 2010-06-29 | New York University | Mycobacterial proteins as early antigens for serodiagnosis and vaccines |
US20030049692A1 (en) * | 2002-09-16 | 2003-03-13 | Norman Latov | Detection of anti-glycolipid antibodies by latex agglutination assay |
GB2424273B (en) * | 2002-11-14 | 2007-06-27 | Univ Nottingham | Method for preparing tumour marker protein |
JP2007525142A (ja) * | 2002-12-27 | 2007-09-06 | アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ フェンノートシャップ | 新規フィブリリン−様ポリペプチド |
JP2005352771A (ja) * | 2004-06-10 | 2005-12-22 | Hitachi Software Eng Co Ltd | 発現プロファイルによるパターン認識システム |
US20060141547A1 (en) * | 2004-11-16 | 2006-06-29 | Das Hasi R | Novel diagnostic marker, a diagnostic kit and a method for diagnosis of rheumatoid arthritis |
GB2426581A (en) * | 2005-05-27 | 2006-11-29 | Univ Nottingham | Immunoassay methods |
EP1789435B1 (en) * | 2005-09-12 | 2010-02-24 | Industry Foundation of Chonnam National University | A method for production of mature natural killer cell |
TWI304443B (en) * | 2005-12-30 | 2008-12-21 | Nat Health Research Institutes | Alpha-enolase specific antibody and method of use |
US8574848B2 (en) * | 2006-09-13 | 2013-11-05 | Oncimmune Ltd. | Immunoassay methods |
CA2663154C (en) * | 2006-09-13 | 2016-02-23 | Oncimmune Ltd | Improved immunoassay methods |
-
2007
- 2007-12-24 GB GBGB0725239.8A patent/GB0725239D0/en not_active Ceased
-
2008
- 2008-12-23 EP EP08865264.9A patent/EP2223114B1/en active Active
- 2008-12-23 ES ES08865264.9T patent/ES2588731T3/es active Active
- 2008-12-23 JP JP2010538909A patent/JP5594776B2/ja not_active Expired - Fee Related
- 2008-12-23 AU AU2008339624A patent/AU2008339624B2/en not_active Ceased
- 2008-12-23 CA CA2707025A patent/CA2707025C/en active Active
- 2008-12-23 WO PCT/GB2008/004260 patent/WO2009081165A1/en active Application Filing
- 2008-12-23 DK DK08865264.9T patent/DK2223114T3/en active
- 2008-12-23 US US12/343,047 patent/US20090176319A1/en not_active Abandoned
- 2008-12-23 SG SG2012095006A patent/SG186684A1/en unknown
- 2008-12-23 BR BRPI0821397A patent/BRPI0821397B1/pt not_active IP Right Cessation
- 2008-12-23 SI SI200831684A patent/SI2223114T1/sl unknown
- 2008-12-23 PT PT88652649T patent/PT2223114T/pt unknown
- 2008-12-23 CN CN200880122385.1A patent/CN101952723B/zh not_active Expired - Fee Related
-
2010
- 2010-05-13 IL IL205733A patent/IL205733A/en active IP Right Grant
-
2011
- 2011-06-23 HK HK11106531.0A patent/HK1152380A1/zh not_active IP Right Cessation
-
2016
- 2016-08-30 HR HRP20161109TT patent/HRP20161109T1/hr unknown
- 2016-09-23 US US15/274,012 patent/US20170074884A1/en not_active Abandoned
- 2016-11-17 CY CY20161101189T patent/CY1118253T1/el unknown
-
2020
- 2020-11-19 US US16/952,473 patent/US20210318320A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US20170074884A1 (en) | 2017-03-16 |
US20210318320A1 (en) | 2021-10-14 |
EP2223114B1 (en) | 2016-08-17 |
SG186684A1 (en) | 2013-01-30 |
HRP20161109T1 (hr) | 2016-11-04 |
BRPI0821397B1 (pt) | 2018-10-09 |
AU2008339624A1 (en) | 2009-07-02 |
CA2707025A1 (en) | 2009-07-02 |
CN101952723A (zh) | 2011-01-19 |
ES2588731T3 (es) | 2016-11-04 |
BRPI0821397A2 (pt) | 2017-05-23 |
US20090176319A1 (en) | 2009-07-09 |
AU2008339624B2 (en) | 2014-11-20 |
GB0725239D0 (en) | 2008-02-06 |
IL205733A (en) | 2014-09-30 |
JP2011508197A (ja) | 2011-03-10 |
IL205733A0 (en) | 2010-11-30 |
DK2223114T3 (en) | 2016-10-24 |
HK1152380A1 (zh) | 2012-02-24 |
CA2707025C (en) | 2020-08-25 |
WO2009081165A1 (en) | 2009-07-02 |
PT2223114T (pt) | 2016-09-29 |
EP2223114A1 (en) | 2010-09-01 |
JP5594776B2 (ja) | 2014-09-24 |
CN101952723B (zh) | 2016-05-11 |
SI2223114T1 (sl) | 2016-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1118253T1 (el) | Υλικο βαθμονομησης για ανοσοποσοτικους προσδιορισμους | |
EA201201101A1 (ru) | Пассивный микрососуд и датчик | |
BR112015022763A8 (pt) | sensor para detectar um analito | |
CY1119287T1 (el) | Συζευγματα αντισωματων πυρρολοβενζοδιαζεπινης-αντι-her2 | |
BR112014020542B8 (pt) | Aparelho e método para determinar a pressão de saturação de um fluido | |
BR112013003633A8 (pt) | técnicas de medição de toque capacitivo verdadeiro e força para sensores de toque capacitivo | |
EA201600085A1 (ru) | Набор для обнаружения соевого события syht0h2 | |
CO6781536A2 (es) | Agonistas de fgfr1 y sus métodos de uso | |
CO6721041A2 (es) | Anticuerpo anti-pcsk9 y métodos de uso | |
GB2538216A (en) | Method of screening candidate biochemical entities targeting a target biochemical entity | |
BR112012027816A2 (pt) | marcadores preditivos úteis no tratamento da síndrome do x frágil (fxs). | |
DK3912551T3 (da) | Fremgangsmåde til kalibrering af en analytsensor | |
CY1120164T1 (el) | Ταψι ψησιματος | |
GB2540323A (en) | Caliper tool with in-situ temperature compensation | |
BR112012002116A8 (pt) | análise pvt de fluídos pressurizados. | |
BRPI0821137A2 (pt) | Disposição de célula de medição de pressão de diafragma | |
WO2010020673A3 (de) | Transkutane organfunktionsmessung | |
MX336109B (es) | Formacion de imagenes inmuno-tep de anticuerpos e inmunoconjugados y usos de lo mismo. | |
CY1123483T1 (el) | Διαταξη δημιουργιας κρουστικων κυματων και μεθοδος απελευθερωσης ενος κρουστικου κυματος | |
BR112018071384A2 (pt) | método para detecção de uma posição de um dispositivo móvel de fundo do poço, e, conjunto de fundo do poço para detecção de uma posição de um dispositivo móvel. | |
IN2015DN01876A (el) | ||
EP2550523A4 (en) | Luminescence lifetime based analyte sensing instruments and calibration technique | |
TR201907065T4 (tr) | Aptamer kullanarak hedef maddeyi tespit yöntemi. | |
FI20075251A0 (fi) | Immunomääritys epästabiilien antigeenien määrittämiseksi | |
DE602007003926D1 (de) | Testen optisch verstärkter Verbindungen mit zeitlich gemultiplexten Testsignalen |